$DSS News

Last published 1w ago

1w agoDSS IBODSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business CombinationACCESS NewswireSpecial meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard TimeUpon closing, the combined company is expected to
1mo agoDSS IBODSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar LimitedGlobeNewswireROCHESTER, N.Y., Sept. 16, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) ("DSS" or the "Company") today announced that Zoar Limited ("Zoar" or "PubCo") has filed a Registration
2mo agoDSSDSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise OperationsGlobeNewswireROCHESTER, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a diversified technology company with experience in enterprise IT services, digital transformation, cybersecurity and authentication
2mo agoDSSDSS, Inc. Announces Decision Not to Proceed with Proposed Public OfferingGlobeNewswireNEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending,
2mo agoDSSDSS, Inc. Announces Launch of Proposed Public OfferingGlobeNewswireNEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending,
5mo agoDSSDSS, Inc. Withdraws Registration StatementGlobeNewswireNEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) today announced that it has withdrawn its previously filed Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission. After
6mo agoDSSDSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K FilingGlobeNewswireROCHESTER, N.Y., May 08, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) announced that its annual report (10-K) for the fiscal year ending December 31, 2025, filed on March 31, 2026, includes an audit opinion from HTL
7mo agoDSSDSS, Inc. Letter to ShareholdersGlobeNewswireROCHESTER, N.Y., April 15, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) today issued the following letter to shareholders from the Interim CEO, Jason Grady, highlighting the Company's operational progress, financial
9mo agoDSSDSS, Inc. Announces Closing of $1.0 Million Underwritten Public OfferingGlobeNewswireNEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and
9mo agoDSSDSS, Inc. Announces Pricing of $1.0 Million Underwritten Public OfferingGlobeNewswireNEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and
9mo agoDSSDSS, Inc. Announces Launch of Proposed Public OfferingGlobeNewswireNEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including packaging, wealth management, and biohealth innovation, today
1y agoDSSDSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic GrowthGlobeNewswireNEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating across diverse industries including packaging, real estate, and biomedical innovation, today announced financial
1y agoDSSSentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities OfferingsGlobeNewswireNEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sentinel Brokers Company, Inc. ("Sentinel"), a FINRA-registered broker-dealer and a subsidiary of DSS, Inc. (NYSE:DSS), is pleased to announce that it has received approval
1y agoDSS IBODSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic GrowthGlobeNewswireROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air purification asset to
1y agoDSSDSS, Inc. Issues Letter to ShareholdersGlobeNewswireNEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) a multinational company operating businesses within diversified market sectors that strategically acquires and develops assets to increase shareholder
2y agoDSS IBODSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder ValueGlobeNewswireNEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE:IBO), is delighted to announce the successful pricing of Impact BioMedical's
2y agoDSSAmericaFirst Funds Trust Announces Changes to Board of TrusteesGlobeNewswireNEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- AmericaFirst Funds, a subsidiary of DSS, Inc. (NYSE:DSS), today announced that effective August 9, 2024, David Friedensohn, Monica Himes and Allan Siegel have resigned from
2y agoDSSDSS, Inc. Names Jason Grady as Interim Chief Executive OfficerGlobeNewswireNEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as Chief Operating Officer of
2y agoDSSImpact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."GlobeNewswireNEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE:DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology
2y agoDSSDSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open MarketGlobeNewswireNEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company")), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the
2y agoDSSDSS, Inc. Announces Reverse Split as Part of NYSE American Compliance PlanGlobeNewswireNEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS, "Company")), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value
2y agoDSSPremier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four YearsGlobeNewswireNEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through
2y agoDSSImpact Biomedical Inc. Files Current Report on Form 8-KGlobeNewswireNEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc. ("the Company" and "Impact") announced today that the Company filed a Current Report on Form 8-K with the Securities and Exchange Commission on
2y agoDSSDSS Inc. Wins Patent Dispute with Nichia CorporationGlobeNewswireNEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) announced today that, in a unanimous decision, the Court of Appeals for the Federal Circuit (CAFC) rejected Nichia Corp.'s challenge to U.S. Patent
3y agoDSSDSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder's Common StockGlobeNewswireNEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) announced today that Impact BioMedical Inc. ("Impact") filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6,
3y agoDSSDSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing RuleGlobeNewswireNEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE:DSS) announced today that the Company received a letter (the "Letter") from the staff of NYSE American LLC (the "Exchange") stating that the Company's
3y agoDSSDSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact BiomedicalGlobeNewswireNEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE:DSS) ("DSS") announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC")
3y agoDSS PRPHDSS Inc. Issues Letter to ShareholdersGlobeNewswireROCHESTER, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through
3y agoDSSDSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management SubsidiaryGlobeNewswireROCHESTER, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- DSS Wealth Management, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce that Jim Monaghan has
3y agoDSSDSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.GlobeNewswireROCHESTER, N.Y., July 31, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build
3y agoDSSDSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.GlobeNewswireROCHESTER, N.Y., July 05, 2023 (GLOBE NEWSWIRE) -- DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce the appointment of Daniel Lew as
3y agoDSSDSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.GlobeNewswireROCHESTER, N.Y., June 30, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build
3y agoDSSDSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special DividendGlobeNewswireROCHESTER, N.Y., June 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build
3y agoDSS SHRGDSS Inc. Announces Distribution Date of Sharing Services Shares to DSS ShareholdersGlobeNewswireROCHESTER, N.Y., May 01, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build
3y agoDSSDSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PMGlobeNewswireROCHESTER, N.Y., April 17, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses in diversified market sectors and strategically acquiring and developing assets to increase
3y agoDSS SHRGDSS Announces Letter to ShareholdersGlobeNewswireROCHESTER, N.Y., March 02, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating nine business divisions through strategic acquisitions and development to enrich
4y agoDSSImpact BioMedical Scientific Partner GRDG Sciences to be Featured in New DocumentaryGlobeNewswireImpact BioMedical is a wholly owned subsidiary of DSS "A Real-Life Mission Impossible" — Global Research and Discovery Group steps in the spotlight for documentary, "The BioQuest" — Filming to start December 3
4y agoDSSDSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q FilingGlobeNewswireROCHESTER, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IP
4y agoDSSImpact BioMedical Develops Quantum AntihistamineGlobeNewswireROCHESTER, N.Y., July 26, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO
4y agoDSS PRPHDSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase LabsGlobeNewswireROCHESTER, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IP
4y agoDSSDSS Strengthens and Expands Board with Appointment of Two Independent DirectorsGlobeNewswireROCHESTER, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IP
4y agoDSS PRPHImpact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound EquivirGlobeNewswireHENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE:DSS), along with its scientific research partner Global Research and Discovery Group Sciences (GRDG), announced today that it signe
4y agoDSSDSS's Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito RepellantGlobeNewswireHENRIETTA, N.Y., June 07, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholde
4y agoDSSDSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®GlobeNewswireROCHESTER, N.Y., May 06, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO
4y agoDSSImpact BioMedical's Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization's ISA DivisionGlobeNewswireROCHESTER, N.Y., March 03, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE:DSS), along with its scientific research partner Global Research and Discovery Group Sciences, (GRDG) announced it had received a
4y agoDSS SHRGDSS Announces Letter to ShareholdersGlobeNewswireROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company with ten operating business lines in diverse, high-growth industries, today announced a letter to shareholders. Dear Shareholde
4y agoDSSDSS to Present at Aegis Virtual ConferenceGlobeNewswireROCHESTER, N.Y., Feb. 22, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company with nine operating business lines in diverse, high-growth industries, today announced that it will present a company overview at
4y agoDSSDSS Receives $17 Million Investment from Alset EHome InternationalGlobeNewswireROCHESTER, N.Y., Jan. 25, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a multinational company with nine operating business lines in diverse, high-growth industries, entered into a stock purchase agreement (the "Agreement") w
4y agoDSS HIPH SHRGAmerican Premium Water Corp. (OTC:HIPH) Announces the Appointment of John "JT" Thatch to Its Board of DirectorsGlobeNewswireThe Company added a seasoned executive to its leadership PLAYA VISTA, California, Jan. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Premium Water Corporation (OTC:HIPH) (the "Company") announces that it has appointed Mr. John "JT" Thatc
4y agoDSSDSS Acquires 25.1% of Alset International LimitedGlobeNewswireDSS adds True Partner Capital with $1.7B AUM into DSS Securities; greatly enhancing the portfolio of the finance and asset management division of DSS ROCHESTER, N.Y., Jan. 19, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. ("DSS" or the "Company") (NYSE:DSS), a